Olidia Malaysia — PLLA Collagen Stimulation

Olidia is an injectable collagen stimulator based on poly-L-lactic acid (PLLA). Rather than filling instantly like a hyaluronic acid filler, it stimulates a gradual tissue response associated with new collagen formation.

Yes. Olidia is available in Malaysia and is offered at Agness Clinic, Kota Damansara, following an individual medical consultation.

Yes. Olidia is registered with Malaysia’s Medical Device Authority as a sterile absorbable PLLA dermal filler.

Olidia is based on poly-L-lactic acid (PLLA), combined with carboxymethylcellulose and mannitol. Exact formulation can differ between Olidia models; manufacturer information should be referred to for each product.

After injection, the carrier is gradually absorbed while PLLA particles remain in the tissue. These particles trigger a biological response, including fibroblast activity, that is associated with progressive collagen formation.

Olidia is registered as an absorbable PLLA dermal filler, but its main clinical concept is collagen stimulation. It is not designed to behave like an instant HA filler.

Olidia and Sculptra are both PLLA collagen stimulators. Differences relate to formulation, preparation and product characteristics, while in practice treatment planning — area, layer and distribution — remains central for both.

Both are PLLA collagen stimulators. The appropriate choice depends on treatment objectives, formulation, treatment planning, tissue characteristics and physician assessment. Neither is universally superior.

Collagen stimulation develops gradually. Any early fullness is largely related to the carrier and settles as it is absorbed; collagen-related change then develops progressively. The pace varies between individuals, so no fixed timeframe can be guaranteed.

Treatment frequency and number of sessions depend on individual anatomy, tissue condition, treatment objective and clinical response.

Papules and nodules are recognised potential complications of PLLA treatment. A palpable nodule is not automatically a granuloma. Preparation, dilution, injection depth, distribution and technique may influence this risk, and follow-up is important.

Granulomatous reactions are distinct inflammatory reactions. They are recognised but uncommon complications of injectable PLLA and other biostimulatory treatments. Any persistent or changing lump should be medically assessed.

The periorbital region is anatomically complex and requires particular caution. Treatment in or around the eye area should not be assumed appropriate simply because a product stimulates collagen. Suitability and treatment options should be assessed individually by the doctor and according to applicable product information.

Because Olidia relies on the body’s own collagen response, duration varies with age, tissue quality, treatment plan and individual biology. No fixed longevity can be guaranteed.

Olidia treatment cost depends on the amount of product, treatment area and individual treatment plan. Please contact Agness Clinic for current pricing and consultation.